RYAN FAULKNER: Open Payments
NPI 1356829147 · CATLETTSBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$550 in 30 payments from 8 companies in 2025. Trend: 2023 $194 · 2024 $346 · 2025 $550
Food & beverage: $550
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $110 |
| PFIZER INC. | 6 | $105 |
| Novo Nordisk Inc | 5 | $102 |
| Lilly USA, LLC | 5 | $91 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
Products named: ELIQUIS, MOUNJARO, VRAYLAR, Rybelsus, BREZTRI, Ozempic, JARDIANCE, Kerendia.
Industry payments across KY — which companies pay providers there.
